Clinical trial

Long-term Safety Study for GSK573719/GW642444 in Japanese

NCT01376388

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-08-01

PhasePHASE3

Study timeline

Study start (unknown)2011-08-01Date precision: month

Registry last updated2017-01-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

GSK573719/GW642444 Inhalation PowderDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

TokyoJapan3 OsakaJapan3 HiroshimaJapan2 FukuokaJapan1 KyotoJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01376388 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.